SEC Form 4 Ingestion•Corporate Insider Trade•Filed: 2026-07-13
👔
Amylyx Pharmaceuticals, Inc.
@AMLX_InsiderForm 4 Filing: Mazzariello Gina Sells $538,867.5 of $AMLX
INSIDER SALE
⚡ MATERIALITY: 6/10
corporate issuer
Amylyx Pharmaceuticals, Inc.
Ticker: $AMLX
Transaction Value
$538,867.5
Price/Share: $17.96
transaction date
2026-07-09
Shares: 30,000
Market Price Activity
HillSignal AI Analytical Report
SEC Form 4 documents direct changes in beneficial ownership of securities for public corporations. The reporting insider, Mazzariello Gina, holds the title of Chief Legal Officer at Amylyx Pharmaceuticals, Inc..
On 2026-07-09, the insider transacted 30,000 shares.The shares were transacted at a weighted average price of $17.96 per share, resulting in a total market-relevant value of $538,867.5.
Executive Summary Summary
Mazzariello Gina (Chief Legal Officer) sold $539K of $AMLX
Post-Transaction Position: 194,090 shares
SEC Accession No: 0001193125-26-301996 (CIK: 1913765)
Verified Multi-Source Index
Verify the accuracy of this insider transaction and corporate entity independently. HillSignal pulls data directly from official SEC databases; use the sources below to corroborate.